CytomX：交易价格接近现金价值，Varseta-M即将迎来关键性试验（纳斯达克：CTMX）
· seekingalpha.com
CytomX Therapeutics凭借Varseta-M在结直肠癌中的强劲数据、现金跑道和上行潜力获得买入评级。在此了解更多关于CTMX股票的信息。
I started my investing journey at age 18, and over the years, I have developed a disciplined strategy that has consistently outperformed the broader market. My ...